Lopatinskaya L - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial.

Vergunst CE, Gerlag DM, Lopatinskaya L, Klareskog L, Smith MD, van den Bosch F, Dinant HJ, Lee Y, Wyant T, Jacobson EW, Baeten D, Tak PP. Vergunst CE, et al. Among authors: lopatinskaya l. Arthritis Rheum. 2008 Jul;58(7):1931-9. doi: 10.1002/art.23591. Arthritis Rheum. 2008. PMID: 18576354 Free article. Clinical Trial.

The development of clinical activity in relapsing-remitting MS is associated with a decrease of FasL mRNA and an increase of Fas mRNA in peripheral blood.

Lopatinskaya L, van Boxel-Dezaire AH, Barkhof F, Polman CH, Lucas CJ, Nagelkerken L. Lopatinskaya L, et al. J Neuroimmunol. 2003 May;138(1-2):123-31. doi: 10.1016/s0165-5728(03)00089-4. J Neuroimmunol. 2003. PMID: 12742662

Elevated osteopontin levels in active relapsing-remitting multiple sclerosis.

Vogt MH, Lopatinskaya L, Smits M, Polman CH, Nagelkerken L. Vogt MH, et al. Among authors: lopatinskaya l. Ann Neurol. 2003 Jun;53(6):819-22. doi: 10.1002/ana.10606. Ann Neurol. 2003. PMID: 12783433

Mediators of apoptosis Fas and FasL predict disability progression in multiple sclerosis over a period of 10 years.

Lopatinskaya L, Zwemmer J, Uitdehaag B, Lucas K, Polman C, Nagelkerken L. Lopatinskaya L, et al. Mult Scler. 2006 Dec;12(6):704-9. doi: 10.1177/1352458506070826. Mult Scler. 2006. PMID: 17262997 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4 results

Search Page

Filters